Skip Navigation and Go To Content
News from The University of Texas Health Science Center at Houston

Stories from The University of Texas Health Science Center at Houston (UTHealth Houston)

Navigation and Search

Health






UTHealth Houston genetic counselor and geneticist help family navigate diagnosis for baby with infantile epileptic seizures

After her diagnosis of a PRRT2 genetic change, which can cause infantile epilepsy and migraines, 4-month-old Parker was switched to a medication that has helped contol her seizures. (Photo courtesy of Kelsey Schneider)

November 8, 2023

In December 2022, while at day care, Kelsey and Joe Schneider’s 4-month-old daughter Parker suffered her first epileptic seizure, suffering a total of six between Christmas and New Year’s Eve, along with two hospitalizations at Children’s Memorial Hermann Hospital. Kelsey had intense, body-numbing migraines herself, but wasn't aware of any family history of seizures.


Active 79-year-old back to marathon rowing following double shoulder replacement

After injuries sidelined him from running marathons, Reuben Bronstein discovered rowing as a new passion. Double shoulder replacements keep the 79-year-old pain-free these days as he rows more than 50 miles a week. (Photo by Logan Ball, UT Physicians)

October 26, 2023

When asked to describe his lifestyle, Reuben Bronstein, age 79, uses the words “extremely physically active” for the last 40+ years. He was a serious marathon runner until stress fractures in his tibia sidelined him. Exercising on the elliptical and treadmill were not replacement options he enjoyed. Then he bought a rower, and it became his second love to running for the past 13 years.




UTHealth Houston expanding drug discovery lab into new TMC3 Collaborative Building

Photo of Zhiqiang An, PhD.

October 19, 2023

The Texas Therapeutics Institute at UTHealth Houston, led by Zhiqiang An, PhD, is expanding into the Texas Medical Center’s newly completed TMC3 Collaborative Building.

The institute, part of The Brown Foundation Institute of Molecular Medicine for the Prevention of Human Diseases with McGovern Medical School at UTHealth Houston, focuses on antibody drug resistance mechanisms, biomarkers for therapeutic antibodies, and antibody drug discovery targeting human diseases.



Previous Page Page 10 of 22

More headlines »

Search UTHealth News

Use the form below to perform a new search.

Give to UTHealth